Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion is additionally listing 18,812 common shares on August 14, 2025, following the exercise of stock options by employees.
📊 [Key Disclosure Details & Financial Summary]
- Disclosure Title: Additional Listing (Exercise of Stock Options)
- Class and Number of Shares: 18,812 registered common shares
- Issue Price per Share (Par Value: KRW 1,000):
- 162nd Tranche: KRW 79,311 (3,659 shares)
- 163rd Tranche: KRW 71,999 (3,223 shares)
- 164th Tranche: KRW 156,285 (5,244 shares)
- 165th Tranche: KRW 156,746 (3,436 shares)
- 166th Tranche: KRW 123,606 (3,250 shares)
- Capital Increase Method: Exercise of stock options
- Issue Date: July 28, 2025
- Dividend Record Date: January 1, 2025
- Listing Date: August 14, 2025
- Stock Code: Standard Code KR7068270008 (Short Code A068270)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Additional Listing Execution on Scheduled Date (August 14, 2025)
This disclosure details the additional listing of 18,812 common shares resulting from the exercise of stock options, making it important to confirm the completion of the listing on the scheduled date of August 14, 2025. Tracking the share issuance ensures verification of the increase in total issued shares. Updated total share counts and capital stock changes can be verified under ‘Total Number of Shares’ and ‘Changes in Capital Stock’ in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).
📢 Disclaimer & Source Information
Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.
Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.
